Thomas DeLaney, MD
Thomas DeLaney, MD
Director, Sarcoma Service, Department of Radiation Oncology
Co-Director, Center for Sarcoma and Connective Tissue Oncology
About Thomas DeLaney, MD
Thomas F. DeLaney, M.D. is a graduate of Harvard College and Harvard Medical School. He trained in Radiation Oncology at the Massachusetts General Hospital (MGH) and spent 6 years as Senior Investigator at the National Cancer Institute. Since 1992, he has been on staff at MGH where he is the Medical Director of the Francis H. Burr Proton Therapy Center and Co-Director of the Center for Sarcoma and Connective Tissue Oncology. He is Professor of Radiation Oncology at Harvard Medical School.
Dr. DeLaney has made important contributions to the treatment of soft tissue sarcomas, bone sarcomas and chordomas, as well as the use of charged particle (proton) radiation therapy. His bibliography lists him as lead author or co-author of 92 original articles in peer-reviewed research publications, as well as 77 reviews, chapters and editorials. He is on the editorial boards of Journal of Surgical Oncology, Journal of Clinical Oncology and UpToDate in Oncology.
Departments, Centers, & Programs:
Clinical Interests:
- Sarcomas
- Proton radiation therapy
- Chordoma
- Osteosarcoma
- Ewing's sarcoma
- Chondrosarcoma
- Liposarcoma
- Brachytherapy (radioactive seeds)
- IORT (Intraoperative Radiation Therapy)
Treats:
- Adult & Pediatrics
Locations
Francis H. Burr Proton Therapy Center
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-6876
Fax: 617-724-9532
Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Therapeutic Radiology, American Board of Radiology
- Radiation Oncology, American Board of Radiology
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
My major research efforts have been in the development and testing of innovative cancer treatment approaches in clinical trials. Primary areas of interest have been soft tissue and bone sarcomas in adults and adolescents, as well as the application of advanced radiation oncology technologies including charged particle radiation with protons and brachytherapy (i.e. placement of radiation sources in close proximity to the tumor to deliver high doses of radiation to the tumor while sparing nearby normal tissue).
Publications
-
View my most recent publications at PubMed
- DeLaney TF et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Rad Oncol Biol Phys. 2003;56:1117-27.
- DeLaney TF et al. Phase II study of high dose photon/proton radiotherapy in the management of spine sarcomas. Int J Rad Oncol Biol Phys 2009; 74: 732-9.
- Kepka L, DeLaney TF, et al. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Rad Oncol Biol Phys 2005; 63:852-9.